Cargando…
Leukocyte telomere length and renal cell carcinoma survival in two studies
BACKGROUND: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent. METHODS: We investigated LTL and RCC-specific survival among 684 cases from the US kidney cancer study (USKC) and 241 cases from the prostate, l...
Autores principales: | Callahan, Catherine L, Schwartz, Kendra, Ruterbusch, Julie J, Shuch, Brian, Graubard, Barry I, Lan, Qing, Cawthon, Richard, Baccarelli, Andrea A, Chow, Wong-Ho, Rothman, Nathaniel, Hofmann, Jonathan N, Purdue, Mark P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572185/ https://www.ncbi.nlm.nih.gov/pubmed/28742796 http://dx.doi.org/10.1038/bjc.2017.237 |
Ejemplares similares
-
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case–control study
por: Hofmann, J N, et al.
Publicado: (2011) -
Family history of cancer and renal cell cancer risk in Caucasians and African Americans
por: Karami, S, et al.
Publicado: (2010) -
Serum leptin and adiponectin levels and risk of renal cell carcinoma
por: Liao, Linda M, et al.
Publicado: (2013) -
Meat-cooking mutagens and risk of renal cell carcinoma
por: Daniel, C R, et al.
Publicado: (2011) -
A Case-Control Study of Peripheral Blood Mitochondrial DNA Copy Number and Risk of Renal Cell Carcinoma
por: Purdue, Mark P., et al.
Publicado: (2012)